Chiltern Wins CRO Leadership Award From Life Science Leader - KXNet - Bismarck/Minot/Williston/Dickinson

Chiltern Wins CRO Leadership Award From Life Science Leader

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE Chiltern

LONDON and WILMINGTON, N.C., March 11, 2013 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has been recognized with a CRO Leadership Award in all five categories: Quality, Reliability, Productivity, Innovation and Regulatory. The awards are given by Life Science Leader publication based on the data-driven research of Nice Insight.

The CRO Leadership Awards were developed to better serve pharmaceutical and biopharmaceutical executives in their vetting process of CROs when they have a new project. On an annual basis, Nice Insight conducts a pharmaceutical and biotechnology survey deployed to over 40,000 outsourcing-facing biotech and pharma executives. Only CROs scoring in the top 20% in each category qualify as CRO Leaders and are selected from over 200 CROs world-wide. Chiltern is one of three CROs winning in all five categories.

Jim Esinhart, Chiltern CEO, commented, "Chiltern is delighted to be recognized by members of the biopharmaceutical industry as a CRO leader in Quality, Reliability, Productivity, Innovation and Regulatory. Chiltern has been serving clients for more than 30 years and has established a track record around the world as an innovative, efficient and flexible full service CRO. It is a great pleasure to accept this award on behalf of all Chiltern colleagues."

Company profile

About Chiltern:
Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs more than 1,500 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com.

©2012 PR Newswire. All Rights Reserved.